Corteva Interim Filing Shows Split Picture as Half-Year Revenue Climbs but Both Windows Post Lower Net Income

Bottom line

- Corteva reported earnings that were lower than the prior year on both the three-month window and the six-month year-to-date window, while revenues told a split story: the quarter finished lower than the prior-year quarter, but the year-to-date six-month window finished higher than the prior-year six-month window. - Across both windows, net income remained a profit on an absolute basis; the move is from a smaller profit to a larger profit in the year-to-date comparison, and from a smaller profit to a larger profit in the quarter comparison — in every case the line stays in positive territory rather than slipping into a loss.

92 per diluted share USD/SHARES — a lower reading on a profit-to-profit transition. 87 per diluted share USD/SHARES — also a lower reading on a profit-to-profit transition. - Net Income (Loss) Attributable to Parent on the three-month reporting period was $1,161,000,000 USD, against $1,314,000,000 USD — lower on a profit-to-profit transition.

- Net Income (Loss) Attributable to Parent on the six-month year-to-date period was $1,881,000,000 USD, against $1,966,000,000 USD — lower on a profit-to-profit transition. - Revenues on the three-month reporting period were $6,379,000,000 USD, against $6,456,000,000 USD — lower than the prior-year quarter. - Revenues on the six-month year-to-date period were $11,284,000,000 USD, against $10,873,000,000 USD — higher than the prior-year six months.

- This filing is filed by Corteva, Inc. under ticker CTVA, CIK 0001755672, on form 10-Q for fiscal period period-ended-2026-06-30, and is the source filing behind accession 0001755672-26-000025. - The interim Consolidated Financial Statements cover the three months ended June 30, 2026 and the year-to-date the six months ended June 30, 2026, with the prior-year comparatives drawn from the three months ended June 30, 2025 and the six months ended June 30, 2025 respectively.

- Within the filing, the item-level disclosures referenced for this analysis include Item 1, Item 1A, Item 2, Item 3, Item 4, Item 5, and Item 6; the note-level references cited are Note 5, Note 6, Note 12, and Note 15. - The interim package is unaudited and is read alongside the company's most recent Annual Report; certain Argentina-related Peso remeasurement disclosures and supplementary reconciliations are carried in the cited note sections. - The filing evidence does not attribute this change to any single cause.

- The filing evidence contains no peer or industry comparison.

Financial performance

YOY - For the three-month reporting period, Earnings Per Share, Diluted was $1.73 per diluted share USD/SHARES versus $1.92 per diluted share USD/SHARES, a decrease on a profit-to-profit basis. - Net Income (Loss) Attributable to Parent for the quarter was $1,161,000,000 USD against $1,314,000,000 USD, also moving lower while remaining profitable. - Revenues for the quarter declined year over year, sitting at $6,379,000,000 USD compared with $6,456,000,000 USD; current remains positive versus a positive prior comparative. - For the six-month year-to-date window, Earnings Per Share, Diluted was $2.8 per diluted share USD/SHARES versus $2.87 per diluted share USD/SHARES, lower on a profit-to-profit transition. - Net Income (Loss) Attributable to Parent for the half year was $1,881,000,000 USD against $1,966,000,000 USD, lower while remaining a profit. - Half-year Revenues were higher year over year, at $11,284,000,000 USD versus $10,873,000,000 USD, both periods positive.

QOQ - The quarterly evidence does not include a sequential prior-quarter window, so quarter-over-quarter movement within the current fiscal year cannot be stated from the provided catalog.

GUIDANCE - The interim Consolidated Financial Statements note that results for interim periods should not be considered indicative of results for a full year, framing the period-to-period comparisons as informational rather than as an annualized outlook. - Management describes the Argentine Peso exposure — Argentina contributes a notable share of annual net sales and segment operating EBITDA — and discloses that the company remeasures net monetary assets at the official Peso to USD rate, with restrictions limiting drawdown of Peso cash balances. The devaluation of the Peso relative to the USD has produced exchange losses in prior periods, and the government has offered USD-denominated bonds to importers for settling intercompany payables, per the interim statements and the cited supplementary notes. - On accounting policy, the filing indicates that interim financial information has been prepared under the Form 10-Q and Regulation S-X rules, with all adjustments consisting of normal recurring items considered necessary for a fair interim presentation. - The statements also note that operations are classified into two segments, Seed and Crop Protection, with revenue disaggregated by major product line and geographic region; recent accounting guidance on expense disaggregation has been issued but not yet adopted by the company, with a future effective date.

EXPECTATIONS - Within the cited notes, management does not provide forward-looking sales or earnings guidance for the remainder of the fiscal year; the interim disclosures focus on policy, segment structure, and the Argentine exposure rather than a numerical outlook. - The catalog contains no company-issued quantitative guidance for the next quarter or the full year, so any forward expectation beyond the filing’s stated interim-period caveat is not present in the filing evidence. - The filing evidence does not attribute this change to any single cause. - The filing evidence contains no peer or industry comparison.

For cross-issuer pattern context, a parallel reading of Broadcom Posts Higher Revenue, Operating Income, and Diluted EPS Year-Over-Year in Filing shows a different directional mix than Corteva's interim windows.

Operating drivers and segments

- The filing identifies two operating segments — Seed and Crop Protection — with no finer disclosure provided in this section's filing evidence. - Reported revenues for the six-month year-to-date period were $11,284,000,000, higher than the prior-year comparative of $10,873,000,000 for the six months ended June 30, 2025. - Reported revenues for the three-month reporting period were $6,379,000,000, lower than the prior-year comparative of $6,456,000,000 for the three months ended June 30, 2025.

- No segment-level revenue, operating EBITDA, or margin figures are included in the filing evidence for this section, so segment direction and margin trend cannot be derived independently. - The filing notes that Argentina contributes approximately (omitted) percent to annual net sales and approximately (omitted) percent to each segment's annual operating EBITDA, but the omitted percentages leave the exact exposure levels unstated in the reader-facing text. - Management attributes no specific cause to the headline revenue movements within the narrative supplying this section; readers should treat the directional facts without an accompanying driver explanation.

- The filing carries forward accounting guidance context: a recently issued ASU on expense disaggregation is referenced as not yet adopted, with a clarifying effective-date update, which is procedural and does not by itself explain quarterly or half-year results. - The devaluation of the Argentine Peso and related USD-access restrictions are flagged as a contextual macro factor, with a note that Peso cash balances face limited repatriation and that intercompany payables may be settled via USD-denominated bonds issued by the Argentine government.

- Management's segment framing is qualitative in the available evidence: it identifies charges associated with the Crop Protection segment but does not quantify a segment-level margin path for either window. - The broader narrative restates corporate-structure definitions (Corteva, EIDP, Dow, DuPont, DowDuPont, Historical Dow, Historical DuPont, the Merger, the Distributions, and the Letter Agreement) and the presentation of discontinued operations, none of which are operational drivers themselves. - The filing evidence does not attribute this change to any single cause.

The filing evidence does not attribute the revenue change to any single cause for either the three-month or six-month windows. - Comparative segmentation practice is also limited here: a broader pattern of profit-to-profit interim filings among healthcare and specialty-product issuers is documented in the Lizely Finance Earnings Analysis — UFP TECHNOLOGIES INC Interim Filing: Profit-to-Profit Growth on Both Windows, though that cross-reference sits outside this filing's own segment disclosure and should not be read as a peer benchmark.

Cash flow and capital

Across the six-month year-to-date window defined as the six months ended June 30, 2026 in this 10-Q filed under accession 0001755672-26-000025, Corteva, Inc. (ticker CTVA) generated a cash outflow from operating activities of -$3,357,000,000 USD, which sits alongside an operating outflow of -$1,162,000,000 USD for the prior-year comparative period the six months ended June 30, 2025. Consistent with the reported comparison for this line, the year-over-year direction is an authorized decrease within the negative band; both periods describe a use of cash rather than a source. The filing evidence does not attribute this change to any single cause.

Investing activities absorbed cash across both windows, with the current six-month period reporting a use of cash of -$247,000,000 USD versus a use of -$198,000,000 USD in the prior-year comparative. The authorized direction is a decrease (a smaller outflow) year-over-year, but no causation is supplied in the cited notes. Financing activities supplied cash in both windows, reported at $1,530,000,000 USD for the current six-month period and $187,000,000 USD for the prior-year comparative; the authorized direction is an authorized increase. Readers comparing interim filings such as the UFP TECHNOLOGIES INC interim analysis and the ANI Pharmaceuticals interim analysis will note the same positive financing lane is common across the interim universe.

Capital returned to shareholders during the current six-month window took the form of $500,000,000 USD in payments for repurchase of common stock and $241,000,000 USD in payments of dividends, compared with $520,000,000 USD and $232,000,000 USD respectively in the prior-year comparative. The authorized direction for repurchases is a decrease and for dividends is an increase, so the buyback envelope shrank while the dividend envelope grew; both lines remain in positive territory, and no causation for the shift is offered here. The filing evidence does not attribute this change to any single cause.

On the balance-sheet side as of the balance sheet date of June 30, 2026, working-capital captions present as follows: Cash and Cash Equivalents, at Carrying Value of $2,365,000,000 USD; Accounts Receivable, after Allowance for Credit Loss, Current of $5,834,000,000 USD; Accounts Payable, Current of $3,958,000,000 USD; and the trade sub-line, Accounts Payable, Trade, Current of $1,691,000,000 USD. These captions frame the liquidity backdrop against which the cash-flow figures above should be read, but the cited interim filing does not pair them with quantitative coverage or working-capital ratio commentary.

Management commentary in Note 5 describes the current restructuring program designed to support the intended separation of Corteva, Inc.'s businesses, including the recently committed next phase covering the intended cessation of production activities at the Asturias, Spain site, with cash payments anticipated to be paid over roughly the next year and severance-related outflows already recorded; The filing evidence does not attribute this change to any single cause. the filing does not break out the split between severance, decommissioning, and contract-termination cash effects on a line-by-line basis within the six-month cash-flow statement. No peer or industry comparison is provided in the filing evidence. The filing evidence contains no peer or industry comparison.

Peer and historical context

- the filing for Corteva, Inc. covers a single reporting entity and provides no peer-company line items, so cross-issuer benchmarking must be deferred. The only factual scaffold available for this section is the issuer's own year-over-year history on the income-statement and cash-flow lines that the catalog carries. - The direction set the catalog authorizes is internally consistent on the half-year window, where Revenues move up but Net Income and Operating Cash Flow move down, which is the same split pattern visible on the quarter window (Revenues down, Net Income down). That pattern is unusual and is the natural focus for this section. - On the half-year window, Revenues were $11,284,000,000 USD versus $10,873,000,000 USD, an increase. Net Income (Loss) Attributable to Parent was $1,881,000,000 USD versus $1,966,000,000 USD, a decrease. Earnings Per Share, Diluted fell alongside Net Income. Operating Cash Flow was a use of -$3,357,000,000 USD, worse than the prior-year use of -$1,162,000,000 USD. - On the quarter window, Revenues were $6,379,000,000 USD versus $6,456,000,000 USD, a decrease, and Net Income (Loss) Attributable to Parent was $1,161,000,000 USD versus $1,314,000,000 USD, a decrease, both profit-to-profit transitions.

- The half-year Revenue increase cuts against the simultaneous half-year decline in Net Income and the larger Operating Cash Flow use, so the top-line improvement does not translate cleanly into bottom-line or cash-conversion improvement on that window. - The quarter window shows the same divergence in the opposite direction: Revenues declined and Net Income also declined, so on the quarter the top-line and bottom-line moves are aligned rather than split.

The filing evidence does not attribute this change to any single cause.

The filing evidence contains no peer or industry comparison.

Scenario analysis

- A continuation of recent trends: revenues tracking close to the prior periods, with the half-year total rising versus the prior-year window and the quarter slipping modestly versus its prior-year comparison, while net income attributable to parent settles lower than the prior year on both windows. - Management's stated restructuring work at the Pittsburg site and the next phase targeting the Asturias facility are treated as in-progress cost-management actions whose cash settlement profile is anticipated in the range described and paid down through the second quarter of the year, with completion expected by the end of the year cited.

- The half-year revenue gain versus the prior-year window widens further if pricing or volume momentum carries into the back half of the year, with the revenue trajectory in the most recent quarter stabilising rather than continuing to track lower. - Net income pressure eases if severance and asset-related charges under the Crop Protection Operations Strategy Restructuring Program roll off toward the planned completion window. - For a sense of how a top-line lift paired with dividend growth can read across another interim filing, see the framing in Reinsurance Group of America Posts Higher Revenue and Net Income in Filing.

- If the quarterly revenue softness extends into the second half, the half-year gain versus the prior-year window narrows, and the net income decline on both the quarter and the half-year deepens. - Restructuring cash payments accelerate toward the upper end of the anticipated range disclosed for the program, pushing operating cash usage above the prior-year outflow while financing activity remains a net inflow on higher dividend payments and lower share repurchase cash use versus the prior-year window. - The filing evidence does not attribute this change to any single cause. - Operating activity stays a net cash use on both windows, narrowing only slightly versus the prior-year period, leaving limited cushion if working-capital or settlement-related outflows tied to contingencies noted in the cited note prove larger than expected.

The scenarios above assume only the year-over-year relations that the filing evidence authorises for revenues and net income on both windows, with no imputation of margin, pricing, or volume drivers. The filing evidence contains no peer or industry comparison, so the conditional paths rest entirely on the company's own reported trajectory, the restructuring cash outlook described, and the dividend-versus-buyback balance for the half-year period. Readers comparing this with interim filings that show profit-to-profit growth on both windows, such as the UFP Technologies interim analysis, should note that Corteva, Inc.'s interim profile shows profit on both windows but with a lower net income figure on each, framed here as three scenarios rather than a single base case.

Risks and what to watch

- Reported facts. The filing for Corteva, Inc. under 10-Q period-ended-2026-06-30 (accession 0001755672-26-000025) shows Net Income (Loss) Attributable to Parent of $1,161,000,000 for the three months ended June 30, 2026 and $1,881,000,000 for the six months ended June 30, 2026, both positive and therefore profit-to-profit on each window against the prior-year comparatives of $1,314,000,000 and $1,966,000,000.

Revenues came in at $6,379,000,000 for the three months and $11,284,000,000 for the six months, against prior-year comparatives of $6,456,000,000 and $10,873,000,000. - Management explanation. The narrative in the filing attributes a portion of period charges to restructuring expected to be substantially complete by the end of a stated horizon and notes that those charges are substantially all associated with the Crop Protection segment.

It also calls out pre-tax exchange gains and losses tied to the Argentine peso devaluation for both the three- and six-month windows of the three months ended June 30, 2026 and the six months ended June 30, 2026, the non-service components of net periodic benefit credits and costs, a reference to settlement activity linked to the Federal Trade Commission Investigation described in Note 12, and a foreign currency hedging program whose pre-tax gains and losses flow through other income (expense), net. - Analyst inference.

The most material qualitative tension is that the half-year top line expanded relative to the prior six-month period even as bottom-line earnings contracted, while on the single quarter revenues fell year over year and earnings also fell. This combination is the main reason the headline read-through is mixed rather than straightforward. - Counter-evidence.

Two buffers sit on the other side of that tension. First, the restructuring item is described as substantially segment-concentrated in Crop Protection and as transitory, which limits the read-across to the rest of the portfolio if the action indeed closes out within the stated window. S.

while the offsetting remeasurement exposure is often not taxable locally — a structural feature that can mute or amplify reported pre-tax results depending on the direction of the move. - Unknowns. The filing evidence does not provide a peer or industry benchmark, and readers looking for a competitive frame should note that The filing evidence contains no peer or industry comparison..

Cause attribution for the quarter-on-quarter revenue decline and the half-year margin compression is also not given as a single driver in the quoted text, so The filing evidence does not attribute this change to any single cause.. - Metrics to watch next period. The half-year direction on Revenues versus the quarter direction is the cleanest split signal: track whether the next the three months ended June 30, 2026 reading re-aligns with the half-year expansion or extends the quarter-on-quarter contraction.

Watch Net Income (Loss) Attributable to Parent for the same profit-to-profit question on each window. Confirm whether the restructuring program is reported as substantially complete by management's stated end-date, and whether the Argentine peso-related exchange line normalizes or remains a swing factor. Finally, monitor the litigation referenced in Note 12 for further settlement activity, since the filing calls out estimated settlements tied to that matter as already inside the three- and six-month results.